Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-24-001772
Filing Date
2024-08-19
Accepted
2024-08-19 17:06:24
Documents
71
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q axim_10q.htm   iXBRL 10-Q 1454551
2 CERTIFICATION axim_ex311.htm EX-31.1 19320
3 CERTIFICATION axim_ex312.htm EX-31.2 19365
4 CERTIFICATION axim_ex321.htm EX-32.1 5620
5 CERTIFICATION axim_ex322.htm EX-32.2 5275
11 axim_10qimg1.jpg GRAPHIC 4881
  Complete submission text file 0001096906-24-001772.txt   6542862

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA axim-20240630.xsd EX-101.SCH 68268
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE axim-20240630_lab.xml EX-101.LAB 377287
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axim-20240630_cal.xml EX-101.CAL 51209
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axim-20240630_pre.xml EX-101.PRE 322009
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axim-20240630_def.xml EX-101.DEF 215390
74 EXTRACTED XBRL INSTANCE DOCUMENT axim_10q_htm.xml XML 885238
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

EIN.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 241221491
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)